A recent cross-sectional, observational study compared the tau spread in people with Down syndrome and autosomal-dominant Alzheimer disease to identify tau-related differences between the two groups.
A retrospective cohort study comparing thick and thin liquid diets for patients with Alzheimer disease and related dementias (ADRD) and dysphagia yielded mixed results.
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
Researchers set out to determine whether microglial activation, which can trigger neuroinflammation, is associated with neuropsychiatric symptoms that often accompany Alzheimer-associated dementias,...
Researchers sought to determine an association between people with hearing loss, their hearing aid use, and the possibility of an increased risk of dementia or Alzheimer disease.
Researchers evaluated the association between phosphodiesterase type 5 inhibitor initiation compared with nonuse and the risk of developing AD in men with erectile dysfunction.
A new expert consensus was released by the American Academy of Neurology reviewing the currently available evidence on the efficacy and safety of antiamyloid monoclonal antibodies for the treatment of...
Researchers found that patients taking suvorexant had reduced levels of amyloid beta and tau phosphorylation, proteins that play a major role in neurodegeneration in Alzheimer disease.
Can a dietary intervention known for reducing cardiovascular risk factors prevent cognitive decline in healthy older individuals? A team of researchers explored this question in a recent study.
